Repligen in Chromatography Pact for Downstream Bioprocessing
Repligen, a life-sciences company focused on bioprocessing technology, has entered into a pact for chromatography with Purolite Life Sciences, a Bala Cynwyd, Pennsylvania-headquartered chemical manufacturing company.
Purolite has agreed to use Repligen’s proprietary OPUS technology, which involves a line of pre-packed chromatography columns, to provide Purolite customers with an end-to-end service for the downstream purification of biologic drugs, specifically monoclonal antibody-based biologics. Under the agreement, Purolite will promote the full range of Repligen’s GMP-ready OPUS pre-packed columns to customers seeking a disposable alternative to self-packed glass columns. The agreement pairs Purolite’s proprietary Praesto Protein A affinity and ion-exchange agarose resins with OPUS.
Source: Purolite Life Sciences